MY102472A - Preparation of funtional human urokinase proteins. - Google Patents

Preparation of funtional human urokinase proteins.

Info

Publication number
MY102472A
MY102472A MYPI87002076A MYPI19872076A MY102472A MY 102472 A MY102472 A MY 102472A MY PI87002076 A MYPI87002076 A MY PI87002076A MY PI19872076 A MYPI19872076 A MY PI19872076A MY 102472 A MY102472 A MY 102472A
Authority
MY
Malaysia
Prior art keywords
preparation
funtional
human urokinase
proteins
urokinase proteins
Prior art date
Application number
MYPI87002076A
Other languages
English (en)
Inventor
William Evans Holmes
Herbert Louis Heyneker
Gordon Alan Vehar
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MY102472A publication Critical patent/MY102472A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
MYPI87002076A 1982-04-15 1987-09-28 Preparation of funtional human urokinase proteins. MY102472A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36877382A 1982-04-15 1982-04-15
US47493083A 1983-03-14 1983-03-14
EP83103629A EP0092182B1 (en) 1982-04-15 1983-04-14 Preparation of functional human urokinase polypeptides

Publications (1)

Publication Number Publication Date
MY102472A true MY102472A (en) 1992-06-30

Family

ID=27004326

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87002076A MY102472A (en) 1982-04-15 1987-09-28 Preparation of funtional human urokinase proteins.

Country Status (20)

Country Link
EP (2) EP0092182B1 (enExample)
JP (3) JPH0655145B2 (enExample)
AT (2) ATE112802T1 (enExample)
AU (1) AU573523B2 (enExample)
BR (1) BR8301918A (enExample)
CA (1) CA1341301C (enExample)
DE (2) DE3382760T2 (enExample)
DK (1) DK173910B1 (enExample)
ES (3) ES521418A0 (enExample)
FI (1) FI88932C (enExample)
GR (1) GR78180B (enExample)
HK (1) HK38297A (enExample)
IE (1) IE64536B1 (enExample)
IL (2) IL68366A (enExample)
MY (1) MY102472A (enExample)
NO (1) NO831317L (enExample)
NZ (1) NZ203869A (enExample)
PH (4) PH24783A (enExample)
PT (1) PT76546B (enExample)
YU (1) YU45128B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
AU587960B2 (en) * 1983-06-24 1989-09-07 Genentech Inc. Procaryotic carbonyl hydrolases
NZ208612A (en) * 1983-06-24 1991-09-25 Genentech Inc Method of producing "procaryotic carbonyl hydrolases" containing predetermined, site specific mutations
EP0139447B1 (en) * 1983-09-13 1992-12-30 The Green Cross Corporation A process for preparing urokinase zymogen
EP0154272B1 (en) * 1984-02-27 1992-01-08 Green Cross Corporation Production of human urokinase
JPS60180591A (ja) * 1984-02-27 1985-09-14 Green Cross Corp:The ヒトウロキナ−ゼのｄνａ配列，プラスミド，宿主
JPS61177987A (ja) * 1985-01-31 1986-08-09 Green Cross Corp:The ヒトウロキナ−ゼの製造方法
JPS61181377A (ja) * 1985-01-25 1986-08-14 Sagami Chem Res Center ヒトウロキナ−ゼ遺伝子
AU5390286A (en) * 1985-01-25 1986-08-13 Sagami Chemical Research Center Stabilized human prourokinase
US5219569A (en) * 1985-04-22 1993-06-15 Genentech, Inc. Protease resistant urokinase
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
US4997766A (en) * 1986-07-11 1991-03-05 American Home Products Corporation Poly-kringle plasminogen activator
JPS62149625A (ja) * 1985-12-25 1987-07-03 Green Cross Corp:The 生理活性物質の製造方法
DE3613401A1 (de) * 1986-04-21 1987-12-17 Boehringer Mannheim Gmbh Verfahren zur herstellung von plasminogen-aktivatoren in prokaryonten
NL8601240A (nl) * 1986-05-15 1987-12-01 Leuven Res & Dev Vzw Plasminogeenactivator en trombolytisch geneesmiddel.
GB8623823D0 (en) * 1986-10-03 1986-11-05 Sandoz Ltd Therapeutic lysis of fibrin blood clots
JPS63105675A (ja) * 1986-10-23 1988-05-10 Green Cross Corp:The ヒトウロキナ−ゼの製造方法
ZA879286B (en) 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
JP2983997B2 (ja) * 1987-01-30 1999-11-29 アメリカン・ホーム・プロダクツ・コーポレイション 脱―表皮細胞成長因子プラスミノーゲンアクチベーター
MY103358A (en) * 1987-04-15 1993-06-30 Novartis Ag Process for the production of protiens.
WO1989001513A1 (fr) * 1987-08-19 1989-02-23 Sagami Chemical Research Center Prourokinase a action rapide
AU2334088A (en) * 1987-10-02 1989-05-18 Zymogenetics Inc. Bar1 secretion signal
AU2354588A (en) * 1987-10-09 1989-04-20 Collaborative Research Inc. Modified low molecular weight plasminogen activator and method of preparation
US4999194A (en) * 1988-01-14 1991-03-12 Collaborative Research, Inc. Two-chain urokinase plasminogen activators for treatment of thrombotic disease
US4920051A (en) * 1988-02-03 1990-04-24 Damon Biotech, Inc. Recovery of urokinase compounds
IE901849A1 (en) * 1989-07-19 1991-06-19 Gruenenthal Gmbh Plasmids, their preparation and their use in the manufacture¹of a plasminogen activator
AU6470590A (en) 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
WO1991006658A2 (en) * 1989-10-24 1991-05-16 Cetus Corporation Infective protein delivery system
DE4101736A1 (de) 1991-01-22 1992-07-23 Gruenenthal Gmbh Neue als plasminogenaktivatoren einsetzbare polypeptide, dafuer codierende plasmide und verfahren zu deren herstellung und deren verwendung
US5888814A (en) * 1994-06-06 1999-03-30 Chiron Corporation Recombinant host cells encoding TNF proteins
JP2003525578A (ja) * 1998-06-26 2003-09-02 クロプテック・デヴェロップメント・コーポレイション 植物ベースの発現システムにおけるウロキナーゼの製造
US6833357B2 (en) 2000-06-20 2004-12-21 The Trustees Of The University Of Pennsylvania Compositions and methods for modulating muscle cell and tissue contractility
US20030040095A1 (en) * 2001-03-16 2003-02-27 Achille Arini Method for the production of pharmaceutically active recombinant proteins
WO2007047995A2 (en) 2005-10-21 2007-04-26 Catalyst Biosciences, Inc. Modified proteases that inhibit complement activation
JP4546578B2 (ja) 2006-07-05 2010-09-15 カタリスト・バイオサイエンシーズ・インコーポレイテッド プロテアーゼスクリーニング方法およびそれにより同定されるプロテアーゼ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3068549D1 (en) * 1979-11-13 1984-08-16 Syed Shaukat Husain Plasminogen activators useful as therapeutic and diagnostic agents and their isolation
US4321363A (en) * 1980-02-21 1982-03-23 Nippon Soda Company Limited Adsorbent for urokinase containing agarose
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
US4506013A (en) * 1980-10-03 1985-03-19 Eli Lilly And Company Stabilizing and selecting recombinant DNA host cells
GR80966B (en) * 1983-11-21 1985-03-15 Ciba Geigy Ag Synthesis of fibrinolytic agents by yeast

Also Published As

Publication number Publication date
ES8500325A1 (es) 1984-11-01
DK163683A (da) 1983-11-28
ATE232237T1 (de) 2003-02-15
EP0092182A2 (en) 1983-10-26
FI88932C (fi) 1993-07-26
PH25120A (en) 1991-02-19
YU45128B (en) 1992-03-10
NO831317L (no) 1983-10-17
JP2584192B2 (ja) 1997-02-19
AU1352483A (en) 1983-10-20
ATE112802T1 (de) 1994-10-15
DE3382760T2 (de) 1995-03-02
EP0620279A1 (en) 1994-10-19
FI88932B (fi) 1993-04-15
GR78180B (enExample) 1984-09-26
DE3382837T2 (de) 2004-01-15
YU86883A (en) 1988-10-31
PT76546B (en) 1986-03-20
IL68366A0 (en) 1983-07-31
FI831228A0 (fi) 1983-04-12
ES8506087A1 (es) 1985-07-01
PH24783A (en) 1990-10-30
PH22461A (en) 1988-09-12
HK38297A (en) 1997-04-04
ES8602121A1 (es) 1985-12-01
EP0092182A3 (en) 1984-07-18
JPS5951300A (ja) 1984-03-24
DE3382837D1 (de) 2003-03-13
PT76546A (en) 1983-05-01
JPH0655145B2 (ja) 1994-07-27
JPH07186A (ja) 1995-01-06
ES521418A0 (es) 1984-11-01
ES533924A0 (es) 1985-07-01
FI831228L (fi) 1983-10-16
DK173910B1 (da) 2002-02-11
EP0092182B1 (en) 1994-10-12
DE3382760D1 (de) 1994-11-17
DK163683D0 (da) 1983-04-14
IE64536B1 (en) 1995-08-09
EP0620279B1 (en) 2003-02-05
IL68366A (en) 1990-08-31
IE950235L (en) 1983-10-15
PH25312A (en) 1991-04-30
JPH0530970A (ja) 1993-02-09
NZ203869A (en) 1987-04-30
JPH0824579B2 (ja) 1996-03-13
CA1341301C (en) 2001-10-09
ES533925A0 (es) 1985-12-01
BR8301918A (pt) 1983-12-20
IE830850L (en) 1983-10-15
AU573523B2 (en) 1988-06-16
IL83236A0 (en) 1987-12-31

Similar Documents

Publication Publication Date Title
MY102472A (en) Preparation of funtional human urokinase proteins.
ATE188486T1 (de) Modifizierte polypeptide mit erhoehter biologischer aktivitaet
DZ467A1 (fr) Interferon immunitaire urbain.
DE3786592D1 (de) Transformation von trichoderma.
ES2156852T3 (es) Citoquina mamifera, il-11.
GR3030811T3 (en) Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
MY103362A (en) Production of proteins in active forms
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
EP0209543A4 (en) FRAGMENTS OF HUMAN APOLIPOPROTEINS PEPTIDES, TYPE-SPECIFIC ANTIBODIES AND METHODS OF USE.
IL81221A0 (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for preparing said proteins and pharmaceutical compositions containing them
NO883834L (no) Nye hiv-proteiner og peptider anvendelige i diagnosen, profylaksen eller terapien av aids.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
EP0676413A3 (en) Interferon alpha / beta binding protein, its production and application.
EP0311228A3 (en) Recombinant polypeptides and their uses, including assay for aids virus
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
DE69033553D1 (de) Rekombinante herstellung von laktoperoxidase
NO910331D0 (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
FI90562C (fi) Uudet Bacillus thuringiensis serovar. israelensis-mutantit, menetelmä itiöttömien, väkevöityjen, sääskille toksisten proteiinipreparaattien valmistamiseksi ja niiden käyttö
NO875477D0 (no) Rekombinant alveolaert overflateaktivt protein.
NO883164L (no) Forsterkende gamma-karboksylering av rekombinant vitamin k - avhengige proteiner.